Required fields are marked with *

Verification code

GP(33-41)TFA

{PARAM:[Name]}()
Category Arenavirus
Description GP(33-41) TFA, a 9-aa-long peptide, is the optimal sequence of the GP1 epitope of lymphocytic choriomeningitis virus
Quotation Now

Product Information

Molecular Weight 1130.19
Molecular Formula C48H70F3N110O15S
Purity 99.70%
Solubility In Vitro:
H2O : 1.82 mg/mL(1.61 mM;ultrasonic and adjust pH to 4 with HCl)
Appearance White to off-white (Solid)
Storage Sealed storage, away from moisture and light
Powder
-80°C 2 years
-20°C 1 years
* In solvent
-80°C 6 months
-20°C 1 month (sealed storage, away from moisture and light)
In Vitro GP(33-41) TFA sensitizes MC57 and T2-Db cells to lysis with ED50s of 0.9±0.6 and 2.5±0.7 nM. The interaction between T cell receptors (TCR) and peptide-major histocompatibility complex (pMHC) antigens can lead to varying degrees of agonism (T cell activation), or antagonism. The P14 TCR recognises the lymphocytic choriomeningitis virus (LCMV)-derived peptide, GP(33-41) (KAVYNFATC), presents in the context of H-2D.
PSA 20.23000
Target Arenavirus

TAKE YOUR NEXT STEPS

Get Started With Our Industry Experience And Client-Centric Focus!

Talk to Us

Copyright © 2024 BOC Sciences. All rights reserved.